Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria.

Hdl Handle:
http://hdl.handle.net/10147/206272
Title:
Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria.
Authors:
O'Sullivan, E P; Avalos, G; O'Reilly, M; Dennedy, M C; Gaffney, G; Dunne, F
Affiliation:
Department of Diabetes, Galway University Hospital, Galway, Ireland.
Citation:
Diabetologia. 2011 Jul;54(7):1670-5. Epub 2011 Apr 15.
Journal:
Diabetologia
Issue Date:
31-Jan-2012
URI:
http://hdl.handle.net/10147/206272
DOI:
10.1007/s00125-011-2150-4
PubMed ID:
21494772
Abstract:
AIMS/HYPOTHESIS: New diagnostic criteria for gestational diabetes mellitus (GDM) have recently been published. We wished to evaluate what impact these new criteria would have on GDM prevalence and outcomes in a predominantly European population. METHODS: The Atlantic Diabetes In Pregnancy (DIP) programme performed screening for GDM in 5,500 women with an oral glucose tolerance test at 24-28 weeks. GDM was defined according to the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria and compared with previous WHO criteria; maternal and neonatal adverse outcomes were prospectively recorded. RESULTS: Of the participants, 12.4% and 9.4% were diagnosed with GDM using IADPSG and WHO criteria, respectively. IADPSG GDM pregnancies were associated with a statistically significant increased incidence of adverse maternal outcomes (gestational hypertension, polyhydramnios and Caesarean section) and neonatal outcomes (prematurity, large for gestational age, neonatal unit admission, neonatal hypoglycaemia and respiratory distress). The odds ratio for the development of these adverse outcomes remained significant after adjustment for maternal age, body mass index and non-European ethnicity. Those women who were classified as having normal glucose tolerance by WHO criteria but as having GDM by IADPSG criteria also had significant adverse pregnancy outcomes. CONCLUSIONS/INTERPRETATION: GDM prevalence is higher when using newer IADPSG, compared with WHO, criteria, and these women and their offspring experience significant adverse pregnancy outcomes. Higher rates of GDM pose a challenge to healthcare systems, but improved screening provides an opportunity to attempt to reduce the associated morbidity for mother and child.
Language:
eng
MeSH:
Adult; Diabetes, Gestational/*diagnosis/*epidemiology/physiopathology; Female; Humans; Infant, Newborn; Pregnancy; Pregnancy Outcome
ISSN:
1432-0428 (Electronic); 0012-186X (Linking)

Full metadata record

DC FieldValue Language
dc.contributor.authorO'Sullivan, E Pen_GB
dc.contributor.authorAvalos, Gen_GB
dc.contributor.authorO'Reilly, Men_GB
dc.contributor.authorDennedy, M Cen_GB
dc.contributor.authorGaffney, Gen_GB
dc.contributor.authorDunne, Fen_GB
dc.date.accessioned2012-01-31T16:35:24Z-
dc.date.available2012-01-31T16:35:24Z-
dc.date.issued2012-01-31T16:35:24Z-
dc.identifier.citationDiabetologia. 2011 Jul;54(7):1670-5. Epub 2011 Apr 15.en_GB
dc.identifier.issn1432-0428 (Electronic)en_GB
dc.identifier.issn0012-186X (Linking)en_GB
dc.identifier.pmid21494772en_GB
dc.identifier.doi10.1007/s00125-011-2150-4en_GB
dc.identifier.urihttp://hdl.handle.net/10147/206272-
dc.description.abstractAIMS/HYPOTHESIS: New diagnostic criteria for gestational diabetes mellitus (GDM) have recently been published. We wished to evaluate what impact these new criteria would have on GDM prevalence and outcomes in a predominantly European population. METHODS: The Atlantic Diabetes In Pregnancy (DIP) programme performed screening for GDM in 5,500 women with an oral glucose tolerance test at 24-28 weeks. GDM was defined according to the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria and compared with previous WHO criteria; maternal and neonatal adverse outcomes were prospectively recorded. RESULTS: Of the participants, 12.4% and 9.4% were diagnosed with GDM using IADPSG and WHO criteria, respectively. IADPSG GDM pregnancies were associated with a statistically significant increased incidence of adverse maternal outcomes (gestational hypertension, polyhydramnios and Caesarean section) and neonatal outcomes (prematurity, large for gestational age, neonatal unit admission, neonatal hypoglycaemia and respiratory distress). The odds ratio for the development of these adverse outcomes remained significant after adjustment for maternal age, body mass index and non-European ethnicity. Those women who were classified as having normal glucose tolerance by WHO criteria but as having GDM by IADPSG criteria also had significant adverse pregnancy outcomes. CONCLUSIONS/INTERPRETATION: GDM prevalence is higher when using newer IADPSG, compared with WHO, criteria, and these women and their offspring experience significant adverse pregnancy outcomes. Higher rates of GDM pose a challenge to healthcare systems, but improved screening provides an opportunity to attempt to reduce the associated morbidity for mother and child.en_GB
dc.language.isoengen_GB
dc.subject.meshAdulten_GB
dc.subject.meshDiabetes, Gestational/*diagnosis/*epidemiology/physiopathologyen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshHumansen_GB
dc.subject.meshInfant, Newbornen_GB
dc.subject.meshPregnancyen_GB
dc.subject.meshPregnancy Outcomeen_GB
dc.titleAtlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria.en_GB
dc.contributor.departmentDepartment of Diabetes, Galway University Hospital, Galway, Ireland.en_GB
dc.identifier.journalDiabetologiaen_GB
dc.description.provinceConnacht-
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.